Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection

DOI: 10.4254/wjh.v9.i4.217

Keywords: Human immunodeficiency virus, Hepatitis C virus, Boceprevir, Pegylated interferon alfa, Ribavirin

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text